Related Experiment Video
Updated: Jan 27, 2026

Live Imaging of Apoptotic Cell Clearance during Drosophila Embryogenesis
Published on: August 18, 2013
Prompt apoptotic response to high glucose in SGLT-expressing renal cells
Linnéa M Nilsson1, Liang Zhang2, Alexander Bondar3
1Science for Life Laboratory, Department of Applied Physics, Royal Institute of Technology, Solna, Sweden.
Abstract:
It is generally believed that cells that are unable to downregulate glucose transport are particularly vulnerable to hyperglycemia. Yet, little is known about the relation between expression of glucose transporters and acute toxic effects of high glucose exposure. In the present ex vivo study of rat renal cells, we compared the apoptotic response to a moderate increase in glucose concentration. We studied cell types that commonly are targeted in diabetic kidney disease (DKD): proximal tubule cells, which express Na+-dependent glucose transporter (SGLT)2, mesangial cells, which express SGLT1, and podocytes, which lack SGLT and take up glucose via insulin-dependent glucose transporter 4. Proximal tubule cells and mesangial cells responded within 4-8 h of exposure to 15 mM glucose with translocation of the apoptotic protein Bax to mitochondria and an increased apoptotic index. SGLT downregulation and exposure to SGLT inhibitors abolished the apoptotic response. The onset of overt DKD generally coincides with the onset of albuminuria. Albumin had an additive effect on the apoptotic response. Ouabain, which interferes with the apoptotic onset, rescued from the apoptotic response. Insulin-supplemented podocytes remained resistant to 15 and 30 mM glucose for at least 24 h. Our study points to a previously unappreciated role of SGLT-dependent glucose uptake as a risk factor for diabetic complications and highlights the importance of therapeutic approaches that specifically target the different cell types in DKD.
Insights
High glucose levels trigger cell death in kidney cells expressing sodium-glucose cotransporter (SGLT) proteins, a key factor in diabetic kidney disease. Targeting SGLT offers a new therapeutic avenue for diabetic complications.
Area of Science:
- Nephrology
- Cell Biology
- Metabolic Diseases
Background:
- Hyperglycemia is a hallmark of diabetes, leading to diabetic kidney disease (DKD).
- The role of specific glucose transporters in the acute cellular response to high glucose is not fully understood.
- Kidney cell types targeted in DKD, including proximal tubule cells, mesangial cells, and podocytes, exhibit differential glucose transporter expression.
Purpose of the Study:
- To investigate the relationship between glucose transporter expression and the acute apoptotic response to hyperglycemia in different rat renal cell types.
- To determine the role of sodium-glucose cotransporter (SGLT)-dependent glucose uptake in high glucose-induced apoptosis.
- To explore potential therapeutic strategies targeting SGLT in the context of DKD.
Main Methods:
- Ex vivo study using rat renal cells (proximal tubule cells, mesangial cells, podocytes).
- Exposure to moderate increases in glucose concentration (15 mM) and albumin.
- Assessment of apoptotic markers (Bax translocation, apoptotic index), SGLT activity, and response to SGLT inhibitors and ouabain.
Main Results:
- Proximal tubule cells (SGLT2) and mesangial cells (SGLT1) showed increased apoptosis within 4-8 hours of high glucose exposure.
- Downregulation of SGLT or treatment with SGLT inhibitors abolished the apoptotic response in these cells.
- Albumin exacerbated the apoptotic response, while ouabain provided protection.
- Podocytes, lacking SGLT and utilizing glucose transporter 4 (GLUT4), remained resistant to high glucose.
Conclusions:
- SGLT-dependent glucose uptake is a significant risk factor for acute cellular injury in DKD.
- Targeting SGLT transporters may offer a novel therapeutic approach for preventing or treating diabetic kidney complications.
- Differential glucose transporter expression influences cell-type-specific vulnerability to hyperglycemia in the kidney.
More Related Videos
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
06:28A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood
Published on: August 12, 2016
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Cell Specific Gene Expression
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: